96556-40-0

Basic information

• Product Name: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-, methyl ester
• CAS NO: 96556-40-0
• Molecular Formula: C13H18O3
• Molecular Weight: 222.284
• Mol File: 96556-40-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-, methyl ester(96556-40-0)
• EPA Substance Registry System: Propanoic acid, 2,2-dimethyl-3-(phenylmethoxy)-, methyl ester(96556-40-0)

Safety Data

• Hazardous Substances Data: 96556-40-0(Hazardous Substances Data)

Upstream product

• 14002-80-3 Methyl 2,2-dimethyl-3-hydroxypropionate 
• 100-39-0 benzyl bromide 

Downstream Products

• 1404379-88-9 C₁₆H₂₂O₃ 
• 1404379-89-0 C₁₆H₂₄O₃ 
• 1404379-90-3 C₁₄H₂₀O₃ 
• 1404379-91-4 C₂₄H₂₉NO₄ 
• 1404379-92-5 C₃₀H₃₉NO₆ 
• 1404379-93-6 C₂₃H₃₃NO₆ 
• 1404379-96-9 C₃₉H₅₆O₄Si 
• 1404379-97-0 C₄₀H₅₉NO₄Si 
• 1404379-98-1 C₃₉H₅₆INO₄Si 
• 1404379-99-2 C₄₂H₆₁NO₄Si 
• 1404380-04-6 C₃₁H₄₄N₂O₄ 
• 1404377-87-2 C₃₀H₄₂N₂O₄ 
• 66582-32-9 3-(benzyloxy)-2,2-dimethylpropan-1-ol 
• 38216-93-2 3-benzyloxypivalic aldehyde 

Relevant articles and documents

Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF1) receptor antagonist BMS-665053 leading to improved oral bioavailability

A series of phosphate and ester-based prodrugs of anilinopyrazinone 1 (BMS-665053) containing either a methylene or an (acyloxy)alkoxy linker was prepared and evaluated in rat pharmacokinetic studies with the goal of improving the oral bioavailability of the parent (1). The prodrugs, in general, had improved aqueous solubility and oral bioavailability compared to 1. Prodrug 12, which contains an (acyloxy)alkoxy linker, showed the greatest improvement in the oral bioavailability relative to the parent (1), with a seven-fold increase (from 5% to 36%) in rat pharmacokinetic studies.

CGRP RECEPTOR ANTAGONISTS WITH TERTIARY AMIDE, SULFONAMIDE, CARBAMATE AND UREA END GROUPS

Compounds of formula I: (I) (wherein variables A, m, n, J, Re, Rf, R4, Ea, Eb, Ec, RPG and Y are as described herein) which are antagonists of CGRP receptors and which are useful

3-‘4-HETEROCYCLYL -1,2,3,-TRIAZOL-1-YL!-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES

Disclosed compounds of formula (I), which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.